arrow
W

William G. Herrick

Frederick National Laboratory for Cancer Research
H指数:7
被引数:358

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Phase I trial of the combination of bortezomib and clofarabine in adults with refractory tumors

I期临床试验:评估硼替佐米与克洛拉拉滨联合方案在难治性肿瘤成人患者中的应用

2026-03-140
OAAI
Phase 1 trial of bortezomib and clofarabine combination in adults with refractory solid tumors
2024-04-050
PRE
Intra-tumoral pharmacodynamics of selumetinib in serial biopsies from patients with neurofibroma
2020-08-150
PRE
Phase II Trial of the MEK 1/2 inhibitor selumetinib (AZD6344, ARRY-142886 hydrogen sulphate) in adults with neurofibromatosis type 1 (NF1) and inoperable plexiform neurofibromas (PN)
2019-12-011
PRE